GSK Non-GAAP EPS of £0.55 beats by £0.04, revenue of £8.89B beats by £50M; reaffirms FY outlook
- GSK press release (GSK): Q3 Non-GAAP EPS of £0.55 beats by £0.04.
- Revenue of £8.89B (+4.0% Y/Y) beats by £50M.
- Specialty Medicines sales £3.9 billion (+15%); HIV sales £2.1 billion (+10%), Respiratory, Immunology & Inflammation £1.1 billion (+21%); Oncology £0.6 billion (+23%).
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.